title: A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma.
authors.forename: Mohamad
authors.initials: M
authors.lastname: Farid
authors.forename: Ying Wei
authors.initials: YW
authors.lastname: Yau
authors.forename: Kevin
authors.initials: K
authors.lastname: Tay
authors.forename: Richard
authors.initials: R
authors.lastname: Quek
authors.forename: Miriam
authors.initials: M
authors.lastname: Tao
authors.forename: Ghee Chong
authors.initials: GC
authors.lastname: Koo
authors.forename: Susan
authors.initials: S
authors.lastname: Loong
authors.forename: Soon Thye
authors.initials: ST
authors.lastname: Lim
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D054391:Lymphoma, Extranodal NK-T-Cell / Q000188:drug therapy*; D016399:Lymphoma, T-Cell / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D011719:Pyrazines / Q000008:administration & dosage; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D001897:Boronic Acids; D009944:Organoplatinum Compounds; D011719:Pyrazines; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000069286:Bortezomib; D007069:Ifosfamide; D000093542:Gemcitabine